IP Library Assignment 051441/0281
Patent Assignment
Reel/Frame 051441/0281

Assignment of Assignor's Interest

Recorded: 2020-01-07 Pages: 12
Assignors
BROOKINGS, DANIEL CHRISTOPHER
Executed: 2018-02-18
BROWN, JULIAN ALISTAIR
Executed: 2018-02-21
HEER, JAG PAUL
Executed: 2018-02-21
JOHNSON, JAMES ANDREW
Executed: 2018-02-21
ZHU, ZHAONING
Executed: 2018-02-21
Assignee
CELLTECH R&D LIMITED
208 BATH ROAD, SLOUGH, BERKSHIRE, SL1 3WE, UNITED KINGDOM
Covered Property (1)
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
Application: 16/487,988 →
Publication: US 2020/0022988
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 7, 2020
From: CELLTECH R&D LIMITED
To: UCB S.A.
Reel/Frame 051441/0376 →
Assignment of Assignor's Interest Jan 7, 2020
From: UCB S.A.
To: UCB PHARMA S.A.
Reel/Frame 051441/0397 →
Assignment of Assignor's Interest Jan 7, 2020
From: UCB PHARMA S.A.
To: UCB BIOPHARMA SPRL
Reel/Frame 051441/0409 →
Assignment of Assignor's Interest Jan 8, 2020
From: UCB BIOPHARMA SPRL
To: SANOFI; UCB BIOPHARMA SPRL
Reel/Frame 051445/0936 →
Change of Name Jan 12, 2021
From: UCB BIOPHARMA SPRL (SOCIETE PRIVEE A RESPONSABILITE LIMITEE)
To: UCB BIOPHARMA SRL (SOCIETE A RESPONSABILITE LIMITEE)
Reel/Frame 054971/0876 →